FDA action counts
| Total FDA actions | 2 |
|---|---|
| Warning letters | 0 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 2 |
| Most recent action | March 13, 2026 |
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. SCA Pharmaceuticals LLC has 2 FDA events on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Enforcement history
On 2026-03-13, Argus HQ recorded an FDA Form 483 inspection citation for SCA Pharmaceuticals LLC, rated "high" severity in Argus HQ's classification: SCA Pharmaceuticals LLC -- FDA 483: 2 observations (2026-03-13). On 2024-12-20, Argus HQ recorded an FDA Form 483 inspection citation for SCA Pharmaceuticals LLC, rated "high" severity in Argus HQ's classification: SCA Pharmaceuticals LLC -- FDA 483: 4 observations (2024-12-20). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Frequently asked questions
- What is the most recent FDA action against SCA Pharmaceuticals LLC?
- The most recent FDA event Argus HQ has on file for SCA Pharmaceuticals LLC is dated 2026-03-13, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- Does Argus HQ track new FDA actions for SCA Pharmaceuticals LLC automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to SCA Pharmaceuticals LLC is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for SCA Pharmaceuticals LLC?
- 2 total: 0 warning letters, 0 recalls, 0 approval records, and 2 Form 483 inspection citations.
- What is the most recent FDA action on file for SCA Pharmaceuticals LLC?
- March 13, 2026. Argus HQ ingests new FDA enforcement records daily.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Regulatory Record: SCA Pharmaceuticals LLC. Digital Empire LLC. Retrieved from https://argushq.ai/company/sca-pharmaceuticals-llc
"Regulatory Record: SCA Pharmaceuticals LLC." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/company/sca-pharmaceuticals-llc.
Argus HQ Research. "Regulatory Record: SCA Pharmaceuticals LLC." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/company/sca-pharmaceuticals-llc.
@misc{argushq_argushq_ai_company_sca_pharmaceuticals_llc_2026,
title = {Regulatory Record: SCA Pharmaceuticals LLC},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/company/sca-pharmaceuticals-llc},
note = {Accessed: July 13, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗